Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 642.49M | 833.38M | 855.00M | 774.80M | 372.66M |
Gross Profit | 91.48M | 98.22M | 48.60M | 97.56M | 13.68M |
EBITDA | 86.04M | 91.88M | 49.08M | 92.67M | 27.69M |
Net Income | 58.17M | 60.94M | 27.70M | 52.36M | 3.00M |
Balance Sheet | |||||
Total Assets | 720.01M | 664.80M | 579.58M | 550.36M | 479.35M |
Cash, Cash Equivalents and Short-Term Investments | 359.07M | 378.66M | 280.94M | 255.72M | 180.69M |
Total Debt | 21.11M | 12.85M | 15.04M | 10.99M | 12.31M |
Total Liabilities | 76.41M | 77.20M | 68.58M | 62.80M | 42.16M |
Stockholders Equity | 560.34M | 513.92M | 447.98M | 430.79M | 384.78M |
Cash Flow | |||||
Free Cash Flow | -7.13M | 90.31M | 39.22M | 86.58M | -1.79M |
Operating Cash Flow | 64.19M | 127.97M | 54.80M | 91.71M | 8.62M |
Investing Cash Flow | -72.86M | 28.40M | -198.51M | 5.29M | -20.79M |
Financing Cash Flow | -18.47M | -4.32M | -17.01M | -11.10M | -22.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $761.32M | 16.28 | 20.93% | 1.11% | 9.92% | 17.12% | |
69 Neutral | $839.75M | 15.81 | 10.68% | ― | -18.36% | -13.81% | |
65 Neutral | $1.13B | 19.69 | 4.77% | 3.07% | 2.64% | 66.43% | |
54 Neutral | $515.35M | ― | -12.34% | ― | -19.82% | -34.91% | |
52 Neutral | $292.27M | ― | -16.11% | ― | 145.38% | -22.02% | |
46 Neutral | $81.07M | ― | -24.43% | ― | -17.27% | -112.62% | |
44 Neutral | AU$1.44B | -5.92 | -41.11% | 4.24% | -3.35% | -41.14% |
On June 4, 2025, Rex American held its annual shareholders meeting, where key decisions were made regarding the company’s governance and financial oversight. Shareholders elected nine directors to the Board for a one-year term, approved executive compensation, and ratified the appointment of an independent registered public accounting firm, reflecting a strong endorsement of the current leadership and strategic direction.
The most recent analyst rating on (REX) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Rex American stock, see the REX Stock Forecast page.